POGO Automatic monitor one-step testing

Too many things keep patients from testing the way they should.1,2

Until now.

The POGO Automatic® Blood Glucose Monitoring System breaks down barriers to help patients achieve their glucose goals.

And with the new customizable levels, patients can now choose from 6 different lance options for a more personalized experience.

A familiar problem: Patients can’t always adhere to a prescribed testing frequency3

To effectively manage their diabetes, patients need to monitor their blood glucose
frequently and actively use the data to correct for abnormal glycemic levels.

But studies show that this isn’t the reality for a majority of patients.

50% of patients don’t meet their
recommended glycemic target4

Many patients have trouble achieving their A1c target. As you can see from the volume of ER and hospital visits, this results in an unwanted outcome.

Three barriers that keep patients from testing

Traditional blood glucose meters create barriers that can cause
patients to either postpone necessary tests or skip them entirely.1,2

POGO Automatic helps make common barriers to testing a thing of the past

With POGO Automatic, patients enjoy three benefits that could help them test more frequently.

Less Hassle

Patients never again have to
handle separate lancets
or test strips.


Patients automatically
lance and test in seconds,
without everyone noticing.


All the work of lancing and blood
collection is automatically done for
patients, simplifying testing.

A simplified testing experience

Load a 10-test cartridge
and turn monitor on.

Press finger on test port
to check blood glucose.

See results
in seconds.

Find out how your patients get POGO Automatic and save on their prescription.

Click here to see how integrated solutions have helped patients improve testing adherence.

References: 1. Blood glucose self-monitoring in diabetes: identifying and dismantling barriers to adherence. Diabetes Management Circle. May 2010. Accessed Nov. 23, 2020. 2. Quest Insight. POGO™ Segmentation and Pricing Study: Draft Research Report. Intuity Medical, Inc. study; Apr. 13, 2012. Unpublished (data on file). 3. Patton SR. Adherence to glycemic monitoring in diabetes.JDiabetes Sci Technol. 2015;9(3):668-675. 4. Centers for Disease Control and Prevention. National Diabetes Statistics Report 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services. Accessed March 4, 2021.